Biography & Education

I see my role as an educator, discussing each patients medical problems in detail. I work with the patient to formulate a treatment plan. I would describe my practice style as very "interactive.
Education Background
Medical School: Johns Hopkins University School of Medicine
Residency: Michael Reese Hospital and Medical Center
Fellowship: University of Chicago Medical Center, IL
  • English

Care Locations

1221 Madison Street
Arnold Pavilion, Suite 200
Seattle, WA 98104
1221 Madison St.
5th Floor
Seattle, WA 98104
Accepting New Patients
Accepting Medicare




Dr. Erin Ellis is the lead investigator for the following clinical trials currently available at the Swedish Cancer Institute:

I-SPY 2 Trial (Investigation of Serial Studies to Predict Your Therapeutic Response with Imaging And moLecular Analysis 2)

A Randomized Phase 2 Study of the Efficacy and Tolerability of Veliparib in Combination with Temozolomide or Veliparib in Combination with Carboplatin and Paclitaxel Versus Placebo Plus Carboplatin and Paclitaxel in Subjects with BRCA1 or BRCA2 Mutation and Metastatic Breast Cancer



WI Bensinger, KS Schiffman, L Holmberg, FR Appelbaum, R Maziarz, P Montgomery, E Elllis, S Rivkin, P Weiden, et al. High-dose busulfan, melphalan, thiotepa, and peripheral blood stem cell infusion for the treatment of metastatic breast cancer. Bone Marrow Transplanation, 1997.

Golom HM and Ellis E. Treatment options for hairy cell leukemia. Seminars in Oncology, 18: 7-11, 1991.

Ellis ED, Williams, SF and Golomb HM. Current advances and guidelines in therapy. In benign and malignant lymphadenopathies: A Guide to Clinical and Laboratory Diagosis, edited by GA Pangalis and A Polliak.

Moormeier JA, Williams SF, Kaminer LS, Ellis ED, Garner M, Farah, Weichselbaum RR, and Bitran JD. Autologous bone marrow transplantation followed by involved field radiotherapy in aptients with relapsed or refractory Hodgkin’s disease. Leukemia and Lymphoma.

Ellis ED, Williams, SF, moormeier JA, Mainer LS, and Bitran JD. A phase I-II study of high dose cyclophosphamide, thiotepa and escalating doses of mitoxantrone with autologous stem cell rescue in patients with refractory malignancies. Bone Marrow Transplatnation, 6: 439-442, 1990.

Ellis ED, Moormeier JA and Golomb HM. The treatment of hairy cell leukemia; a review. Leukemia and Lymphoma, 1: 77-85, 1990.

Le Beau MM, Bitter MA, Larson RA, Doane LA, Ellis ED, Franklin WA, Rubin CM, Kadin ME and Varidman JW. The t(2;5)(p23;q35): A recurring chromosomal abnormality in Ki-1 positive anaplastic large cell lymphoma. Leukemia, 3: 866-870, 1989.


Ellis E, Vokes E, Hoffman P, Krishnasamy S, Gradishar W, English C, Ferguson M, Haraf D, Bitran J and Golomb H. A phase II study of neoadjuvant chemotherapy and concomitant chemoradiotherapy for stage III lung cancer. Proceedings of ASCO, 1991.

Bitran JD, Vokes EE, Hoffman PC, Ellis ED, Gradishar W and Golomb HM. Combines modality therapy for stage III non-small cell lung cancer (NSCLC). Third International Congress on Neoadjuvant Chemotherapy, February 6-9, 1991.

Ellis ED, Williams SF, Moormeier JA, Bitran JD and Ratain MJ. A phase I study of high dose amonafide with autologous bone marrow rescue (ABMR). American Federation for Clinical Research, Midwest Section, November 1, 1990.

Ellis E, Moormeier J, Williams S, Kaminer L, Mick R, Bitran J. A phase II study of mitoxantrone, vincristine, and 5-fluorouracil with leucovorin (MVFL) as induction chemotherapy in women with stage IV breast cancer. 13th Annual San Antonio Breast Cancer Symposium, November 2-3, 1990.

Ellis E, Moormeier J, Kaminer L, Mick R, Williams S and Bitran J. A phase I-II study of high dose cyclophosphamide, thiotepa and mitoxantrone (CTM) in autologous bone marrow reinfusion (ABMR) in patients with refractory malignancies. Proceedings of ASCO, 9: 17, 1990.


Board Certifications
  • Medical Oncology
Clinical Interests
  • Breast Cancer
  • Genetic Counseling
  • Medical Oncologists
  • Medical Oncology
  • Practice Limited to Breast Cancer


Patient Ratings and Comments
About Our Survey

The Patient Rating score is based on responses given during the CAHPS Patient Experience Survey. Responses are measured on a 10-point scale, with 10 being the best score. These scores are then translated to a 5-point scale in order to display results in a 5-star rating. Comments are also gathered from the same survey and displayed in their entirety with the exception of any language that may be considered slander, libel or contain private health information, which will be removed prior to publishing the comments.

4.7 out of 5 (175 Ratings, 20 Comments)


[...] Dr. Ellis is the best!

Dr Ellis is the reason I am alive today 8 years after my diagnosis [...]. I have recommended her to many people...she is great!!

I literally trust Dr. Ellis with my life

Dr. Ellis is a specialist, and a very good one [...]

Best dr. for me.

A friend recommended Dr. [...] (who she had used). [...] in that office made a consultation appt with Dr. Ellis my first appt. I am exceedingly grateful, as BOTH are amazing Drs. [...]

I saw 3 other doctors before deciding on having Dr. Ellis be my doctor for my breast cancer care and I am so glad that I did. Three years later I am cancer-free!

No bad experience with Dr. Ellis.

They are very helpful and always ask me if I have any questions. If I don't understand they will spend time to explain it to me. I always feel at ease with them.

Dr. Ellis is incredibly friendly and helpful. She makes you feel like you are her only patient that day.


Dr. Ellis is an excellent oncologist. My visits are 6 mo. apart.

Dr Ellis is always been friendly and make you feel at ease. I would definitely recommend her to my families and friends.

Helpful and informed care.

Dr. Ellis has managed one crisis after another - unexpected - crisis w/the utmost professionalism - but also compassion & a good sense of humor, helping me cope the very best I can, too, till we "come out of the woods."

I have already recommended them and SCI to others.

This was an annual well-patient visit with my oncologist. I finished my cancer treatment 7 years ago, and have had no recurrence. Therefore, there was no discussion of pain or medication. Dr. Ellis is always exceptional about inquiring about, and caring for, my overall well-being as a cancer survivor.

Dr Ellis has been my Oncologist since 1999. She successfully treated my [...] in 1999 and my [...] in 2013. I have literally entrusted my life to her and she has been stellar! She always is on top of the latest research and makes sure that I directly benefit from her knowledge. I am certain my quality of life and health is a direct reflection of her expertise, her caring and her skilled execution of treatment options. I cannot say enough good things about Dr Ellis and recommend her most highly!!

I don't have any negative experience. They're all positive.

dr. Ellis is one of the best. She is knowledgeable, compassionate and spends the time I need with me.